EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications

Nagarjuna Prakash Dalbanjan, Karuna Korgaonkar, Manjunath P. Eelager, Basavaraj Neelappa Gonal, Arihant Jayawant Kadapure, Suresh B. Arakera, Praveen Kumar S.K.

Nano TransMed · 2025-12 · 4 · 100091

DOI: 10.1016/j.ntm.2025.100091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano TransMed, 2025-12. Verfasst von Nagarjuna Prakash Dalbanjan und 6 weiteren Autor:innen. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Defence Science and Technology Group.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid advancements in nanotechnology have transformed drug design and delivery systems, allowing for precise and efficient therapeutic interventions. This review examines the transformative role of in-silico approaches in nano-drug design, focusing on their ability to predict, optimize, and refine nanomaterial properties for pharmacological applications. Key computational tools such as molecular modelling, machine learning, computational fluid dynamics, and bioinformatics are thoroughly investigated, with a focus on their contributions to understanding drug loading, toxicity, targeting strategies, and nano-bio interactions. Furthermore, the incorporation of emerging technologies like digital twins and quantum computing shows the potential to overcome current limitations in accuracy, scalability, and personalization. Despite significant progress, challenges remain, particularly in closing the gap between computational predictions and experimental validations, dealing with data quality issues, and navigating regulatory frameworks. This review emphasizes the importance of interdisciplinary collaboration and innovation in realizing the full potential of in-silico methods for advancing nanotherapeutics. Addressing these challenges positions the field to accelerate the development of safe, effective, and personalized medicines.

Förderung

  • Defence Science and Technology Group

Zitieren

APA

Dalbanjan, N. P., Korgaonkar, K., Eelager, M. P., Gonal, B. N., Kadapure, A. J., Arakera, S. B., & S.K., P. K. (2025). In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications. Nano TransMed, 4, 100091. https://doi.org/10.1016/j.ntm.2025.100091

Vancouver

Dalbanjan NP, Korgaonkar K, Eelager MP, Gonal BN, Kadapure AJ, Arakera SB, et al. In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications. Nano TransMed. 2025;4:100091. doi:10.1016/j.ntm.2025.100091

BibTeX
@article{Dalbanjan2025,
  author = {Dalbanjan, Nagarjuna Prakash and Korgaonkar, Karuna and Eelager, Manjunath P. and Gonal, Basavaraj Neelappa and Kadapure, Arihant Jayawant and Arakera, Suresh B. and S.K., Praveen Kumar},
  title = {In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications},
  journal = {Nano TransMed},
  year = {2025},
  volume = {4},
  pages = {100091},
  doi = {10.1016/j.ntm.2025.100091}
}
Kostenlos starten →